Although the effectiveness of cannabinoids in CDD rodent models has not been extensively studied to date, several mouse Cdkl5 models have been developed that could be used to evaluate cannabinoids [71,115,116,117]. Here, CDKL5 is linked to craniodiaphyseal dysplasia.